Publication:
Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

Simple item page
dc.contributor.authorsOzbalak, Murat; Akay, Olga Meltem; Pehlivan, Mustafa; Yildiz, Birol; Uzay, Ant; Yigenoglu, Tugce Nur; Elverdi, Tugrul; Kaynar, Leylagul; Ayyildiz, Orhan; Hindilerden, Ipek Yonal; Goksoy, Hasan Sami; Guner, Sebnem Izmir; Gunes, Ahmet Kursad; Sonmez, Mehmet; Yuksel, Meltem Kurt; Bozdag, Sinem Civriz; Ozkurt, Zubeyde Nur; Toptas, Tayfur; Dogu, Mehmet Hilmi; Salim, Ozan; Saydam, Guray; Yavasoglu, Irfan; Ayli, Meltem; Ozet, Gulsum; Albayrak, Murat; Atesoglu, Elif Birtas; Toprak, Selami K.; Yildirim, Rahsan; Mehtap, Ozgur; Besisik, Sevgi Kalayoglu; Nalcaci, Meliha; Altuntas, Fevzi; Ferhanoglu, Burhan
dc.date.accessioned2022-03-10T18:03:19Z
dc.date.accessioned2026-01-11T13:36:35Z
dc.date.available2022-03-10T18:03:19Z
dc.date.issued2021
dc.identifier.doidoiWOS:000691910500283
dc.identifier.eissn2152-2669
dc.identifier.issn2152-2650
dc.identifier.urihttps://hdl.handle.net/11424/222465
dc.identifier.wosWOS:000691910500283
dc.language.isoeng
dc.publisherCIG MEDIA GROUP, LP
dc.relation.ispartofCLINICAL LYMPHOMA MYELOMA & LEUKEMIA
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectrelapsed and refractory
dc.subjectHodgkin lymphoma
dc.subjectbrentuximab vedotin
dc.subjectautologous stem cell transplantation
dc.subjectconsolidation
dc.titleBrentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPageS369
oaire.citation.startPageS368
oaire.citation.titleCLINICAL LYMPHOMA MYELOMA & LEUKEMIA
oaire.citation.volume21

Files

Collections

Araştırma Çıktıları